Sickle cell anemia (SCA) is a clinical form within the spectrum of sickle cell disease (SCD), determined by a point mutation in the beta-globin gene (HBB) in humans, which results in the synthesis of the hemoglobin S (HbS) variant in homozygosis [1]. Here, HBB is linked to autosomal dominant cerebellar ataxia.